Early Data For GeoVax COVID-19 Vaccine Point To Efficacy In Immunocompromised Population

 
• By Alaric DeArment and Sarah Karlin-Smith
  
GeoVax presented early data for the GEO-CM04S1 COVID-19 vaccine • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip